Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Şükran Yılmaz"'
Autor:
Levent Altintas, Mahmut Sözmen, Ismail Tuncer Degim, Gulen Melike Demirbolat, Şükran Yılmaz, Taibe Arsoy
AIM An effective, dual drug(DD) loaded nanocarrier system (nano particle(NP), quantum dots(QDs)) having two active substances was aimed to develop for the treatment of fibrosarcoma. METHODS Zinc oxide(ZnO) QDs were produced using zinc acetate dehydra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685ae05635f61f421a190820c84bc93a
https://hdl.handle.net/20.500.12445/2771
https://hdl.handle.net/20.500.12445/2771
© 2020 Elsevier B.V.Breast cancer is the most common type of cancer and it is the second common cause of cancer-related deaths in women. Hormonal therapy is a quite well-tolerated treatment, for estrogen receptor (ER) and progesterone receptor-posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755b5e3eca20c5ab87aaf2eb1cebe542
https://hdl.handle.net/20.500.12445/1171
https://hdl.handle.net/20.500.12445/1171
Publikováno v:
Mikrobiyoloji Bulteni. 2018:147-155
Macrophages are accepted as cells that initially contact with the pathogens and initiate the innate immune response. They play effective roles in innate immune and inflammatory responses by intercellular relations and inflammatory mediator secretion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd7065f7125793cb87f18beb93a93d9
https://doi.org/10.5578/mb.66745
https://doi.org/10.5578/mb.66745
Publikováno v:
Drug Development Research.
Degim, Zelihagul/0000-0003-2596-3615; ALTINTAS, Levent/0000-0002-5148-723X WOS: 000479314100004 PubMed: 30901500 The main challenges in treating cancer using chemotherapeutics are insufficient dose at the target site and the development of drug resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105543ccf1a715da5a112722de53b543
https://doi.org/10.1002/ddr.21530
https://doi.org/10.1002/ddr.21530
Publikováno v:
Turkish Journal of Pharmaceutical Sciences, Vol 13, Iss 1, Pp 69-80 (2016)
Cisplatin is a potent anticancer drug for treating tumors, that has long been widely used. The therapeutic exploitation of cisplatin is limited by its toxicity toward healthy tissues. Liposomes can provide enhanced efficacy and/or reduced toxicity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e679d17c140d872e11e4da21090913
https://doi.org/10.5505/tjps.2016.32032
https://doi.org/10.5505/tjps.2016.32032
Publikováno v:
Volume: 48, Issue: 3 82-88
İstanbul Journal of Pharmacy
İstanbul Journal of Pharmacy
DOI : 10.26650/IstanbulJPharm.2018.180013 Biorelevant media are used to simulate the physiological conditions in terms of components, pH, osmolality and buffer capacity of the human stomach and intestine in both fasted and fed states In this study, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a508ca8f0334d0f3c44fe9c6d18e15
https://dergipark.org.tr/tr/pub/iujp/issue/42527/512476
https://dergipark.org.tr/tr/pub/iujp/issue/42527/512476
This study is financially supported by the Scientific and Technological Research Council of Turkey (TUBITAK, No. 213M675).
Nanoparticulate systems have been receiving a significant attention especially for the treatment of cancer but one of the
Nanoparticulate systems have been receiving a significant attention especially for the treatment of cancer but one of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a0afba6d9b6b8932a7cfa715f7deb2f
https://avesis.gazi.edu.tr/publication/details/6ac0d58f-aa26-4699-b2c6-4ca7f2afaef6/oai
https://avesis.gazi.edu.tr/publication/details/6ac0d58f-aa26-4699-b2c6-4ca7f2afaef6/oai
Autor:
Mahmut Sözmen, Şükran Yılmaz, Çiğdem Yücel, Yeşim Aktaş, Taibe Arsoy, Levent Altintas, Zelihagül Değim, Can Çokçalışkan
This work was carried out at the Faculty of Pharmacy of Gazi University as a PhD thesis and supported by the Scientific and Technological Research Council of Turkey (TUBYTAK, No. 112S405).
The present study, aims to investigate and compare the e
The present study, aims to investigate and compare the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb6ea39bd33d74955e4b3e22a20d82b
https://hdl.handle.net/20.500.12445/647
https://hdl.handle.net/20.500.12445/647
Background: Platinum complexes as antitumor agents have received considerable attention due to the clinically approved and have been marketed worldwide such as cisplatin, carboplatin, oxaliplatin or marketed locally such as nedaplatin, lobaplatin and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c131a6f81b36aa2dbc7d2363627c52
https://avesis.gazi.edu.tr/publication/details/daafbd52-132a-4a40-b1bc-a53d0c29ac7d/oai
https://avesis.gazi.edu.tr/publication/details/daafbd52-132a-4a40-b1bc-a53d0c29ac7d/oai
Autor:
Ongun Mehmet Saka, Burcu Devrim, Asuman Bozkir, Taibe Arsoy, Berrin Küçüktürkmen, Şükran Yılmaz
Publikováno v:
Drug development and industrial pharmacy. 43(1)
Combination therapy using anticancer drugs and nucleic acid is a more promising strategy to overcome multidrug resistance in cancer and to enhance apoptosis. In this study, lipid-polymer hybrid nanoparticles (LPNs), which contain both pemetrexed and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2cc01fd6523e2aadba599eb3122ea0
https://pubmed.ncbi.nlm.nih.gov/27277750
https://pubmed.ncbi.nlm.nih.gov/27277750